CKD-397 Drug-drug Interaction Study (B)

NCT02247505 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chong Kun Dang Pharmaceutical